We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-0.89%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$849M
AUM Growth
+$64.3M
Cap. Flow
+$67.4M
Cap. Flow %
7.94%
Top 10 Hldgs %
45.35%
Holding
87
New
28
Increased
23
Reduced
11
Closed
22

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$19.2M
2
INCY icon
Incyte
INCY
+$18.5M
3
ASRT
Assertio
ASRT
+$17.4M
4
DKS icon
Dick's Sporting Goods
DKS
+$15.9M
5
CPB icon
Campbell Soup
CPB
+$15M

Top Sells

Rank Stock Value
1
HAIN icon
Hain Celestial
HAIN
+$27.8M
2
SGI
Somnigroup International
SGI
+$20.7M
3
PRKS icon
United Parks & Resorts
PRKS
+$13.7M
4
GCI
Gannett Co., Inc
GCI
+$13.4M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 30.77%
2 Consumer Discretionary 18.98%
3 Consumer Staples 9.7%
4 Industrials 3.8%
5 Technology 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGI
76
Somnigroup International
SGI
$15.2B
– –
-1,400,000
Closed -$20.7M
BBBY
77
DELISTED
Bed Bath & Beyond Inc
BBBY
– –
-352,000
Closed -$10.7M
ALXN
78
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-100,000
Closed -$12.2M
JCP
79
DELISTED
J.C. Penney Company, Inc.
JCP
– –
-1,800,000
Closed -$8.37M
AVEO
80
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
– –
-160,000
Closed -$3.55M
SFS
81
DELISTED
Smart & Final Stores, Inc.
SFS
– –
-364,000
Closed -$3.31M
SGYP
82
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
– –
-2,000,000
Closed -$8.9M
AET
83
DELISTED
Aetna Inc
AET
– –
-64,000
Closed -$9.72M
AVXS
84
DELISTED
AveXis, Inc. Common Stock
AVXS
– –
-36,000
Closed -$2.96M
RXDX
85
DELISTED
Ignyta, Inc.
RXDX
– –
-1,000,000
Closed -$10.3M
GCI
86
DELISTED
Gannett Co., Inc
GCI
– –
-1,536,000
Closed -$13.4M
1 2 3
4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Armistice Capital held 87 positions worth $849M, up 8.2% from $785M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Armistice Capital deployed $67.4M of net new capital in Q3 2017, opening 28 new positions and adding to 23 existing holdings. Its largest new stake was United Therapeutics: 150,000 shares worth $17.6M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Momenta Pharmaceuticals, Inc., an estimated $11.5M trimmed.

  • Armistice Capital's largest Q3 2017 buy was United Therapeutics: 150,000 shares worth $17.6M.
  • Armistice Capital added most to Assertio in Q3 2017, an estimated $17.4M increase.
  • Armistice Capital's biggest Q3 2017 reduction was Momenta Pharmaceuticals, Inc., cutting an estimated $11.5M.
  • Armistice Capital fully exited Hain Celestial in Q3 2017, selling an estimated $27.8M.
  • Armistice Capital's ten largest holdings make up 45% of its $849M portfolio in Q3 2017.
  • Armistice Capital opened 28 new positions and closed 22 in Q3 2017.
  • Armistice Capital's portfolio value rose 8.2% quarter-over-quarter to $849M.

Based on Armistice Capital's 13F filing for Q3 2017, filed 14 Nov 2017.